Plasma Lipidomic n-6 Polyunsaturated Fatty Acids and Type 2 Diabetes Risk in the EPIC-Potsdam Prospective Cohort Study
Artikel i vetenskaplig tidskrift, 2023

OBJECTIVE: Evidence on plasma n-6 polyunsaturated fatty acids (PUFAs) and type 2 diabetes risk is inconsistent. We examined the associations of lipid class-specific PUFA concentrations with type 2 diabetes risk. RESEARCH DESIGN AND METHODS: In the prospective European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort (nested case-cohort study: subcohort 1,084 participants, 536 participants with type 2 diabetes, median follow-up 6.5 years), we measured plasma 18:2, 20:3, and 20:4 concentrations in 12 lipid (sub)classes, likely reflecting the plasma concentrations of linoleic acid (18:2n-6), dihomo-γ-linolenic acid (20:3n-6), and arachidonic acid (20:4n-6). The Δ-5 desaturase (D5D) activity was estimated as the 20:4/20:3 ratio. Associations with diabetes were estimated with Cox proportional hazards models. RESULTS: Higher concentrations of 18:2 were inversely associated with type 2 diabetes risk, particularly in lysophosphatidylcholines (hazard ratio [HR] per 1 SD 0.53; 95% CI 0.23-1.26) and monoacylglycerols (HR 0.59; 0.38-0.92). Higher concentrations of 20:3 in phospholipid classes phosphatidylcholines (HR 1.63; 1.23-2.14), phosphatidylethanolamines (HR 1.87; 1.32-2.65), and phosphatidylinositol (HR 1.40; 1.05-1.87); free fatty acids (HR 1.44; 1.10-1.90); and cholesteryl esters (HR 1.47; 1.09-1.98) were linked to higher type 2 diabetes incidence, and these associations remained statistically significant after correction for multiple testing. Higher 20:4 concentrations were not associated with risk. The estimated D5D activity in phospholipids and cholesteryl esters was associated with lower type 2 diabetes risk. Single nucleotide polymorphisms in the D5D-encoding FADS genes explained relatively high proportions of variation of estimated D5D activity in those lipid classes. CONCLUSIONS: Plasma n-6 PUFAs were associated differently with type 2 diabetes, depending on fatty acid and the lipid class.

Författare

Marcela Prada

Deutsches Zentrum für Diabetesforschung

Deutsches Institut für Ernährungsforschung

Fabian Eichelmann

Deutsches Institut für Ernährungsforschung

Deutsches Zentrum für Diabetesforschung

Clemens Wittenbecher

Chalmers, Life sciences, Livsmedelsvetenskap

Deutsches Institut für Ernährungsforschung

Olga Kuxhaus

Deutsches Institut für Ernährungsforschung

Deutsches Zentrum für Diabetesforschung

Matthias B. Schulze

Universität Potsdam

Deutsches Zentrum für Diabetesforschung

Deutsches Institut für Ernährungsforschung

Diabetes care

19355548 (eISSN)

Vol. 46 4 836-844

Ämneskategorier

Endokrinologi och diabetes

Kardiologi

Näringslära

DOI

10.2337/dc22-1435

PubMed

36787959

Mer information

Senast uppdaterat

2023-09-01